RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.

The positive transcription elongation factor (P-TEFb) consists of CDK9, a cyclin-dependent kinase and its cyclin T partner. It is required for transcription of most class II genes. Its activity is regulated by non-coding RNAs. The 7SK cellular RNA turns the HEXIM cellular protein into a P-TEFb inhibitor that binds its cyclin T subunit. Thus, P-TEFb activity responds to variations in global cellular transcriptional activity and to physiological conditions linked to cell differentiation, proliferation or cardiac hypertrophy. In contrast, the Tat activation region RNA plays an activating role. This feature at the 5' end of the human immunodeficiency (HIV) viral transcript associates with the viral protein Tat that in turn binds cyclin T1 and recruits active P-TEFb to the HIV promoter. This results in enhanced P-TEFb activity, which is critical for an efficient production of viral transcripts. Although discovered recently, the regulation of P-TEFb becomes a paradigm for non-coding RNAs that regulate transcription factors. It is also a unique example of RNA-driven regulation of a cyclindependent kinase.
AuthorsAnnemieke A Michels, Olivier Bensaude
JournalBiotechnology journal (Biotechnol J) Vol. 3 Issue 8 Pg. 1022-32 (Aug 2008) ISSN: 1860-7314 [Electronic] Germany
PMID18655042 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cyclins
  • Protein Subunits
  • Ribonucleoproteins
  • RNA
  • Positive Transcriptional Elongation Factor B
  • Cyclin-Dependent Kinase 9
  • Cyclin-Dependent Kinase 9 (chemistry, metabolism)
  • Cyclins (chemistry, metabolism)
  • Gene Expression Regulation, Enzymologic (physiology)
  • Positive Transcriptional Elongation Factor B (chemistry, metabolism)
  • Protein Subunits
  • RNA (chemistry, metabolism)
  • Ribonucleoproteins (chemistry, metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: